Orchid Pharma Limited has informed the Exchange about Board Meeting held on 10-Aug-2022 to considered, approved and taken on record the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter Ended June 30, 2022 (Q1 of Financial year 2022-23) along with the Limited Review Report (s) of the Statutory Auditors on the same
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.